Cipla Limited vs. Gilead Sciences, Inc.

Explore the PTAB proceeding IPR2025-00033 filed by Cipla Limited on 2024-10-28. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-00033

Filing Date

2024-10-28

Accorded Filing Date

2024-10-28

Institution Decision Date

2025-05-15

Last Modified Date

2025-07-01

Proceeding Type

IPR

Termination Date

2025-05-15

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Cipla Limited

Represented By

Larsen, Andrewet al

Patent Owner / Respondent

Gilead Sciences, Inc.

Represented By

Fasulo, Meget al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17738803

Respondent Patent Number 11744802

External Links

Espacenet

Google Patents

Respondent Inventor Benjamin Micah Collman et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

29 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name GILEAD SCIENCES, INC

Customer Number 25000

Address 333 LAKESIDE DR, FOSTER CITY, CA, 94404, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
40314	David Rubin	917-319-9571
46226	Jennifer Wahlsten	650-372-4447
46567	Brandon Boss	650-522-4626
53551	Tony Sanny	650-522-4225
53866	Joel Silver	650-425-8919
55140	Mary Edwards	650-522-1816
56856	Manali Dighe	707-731-3817
62991	Achim Brinker	619-398-6322
63686	Alexis Simpson	404-885-3098
63700	Timothy Marquart	650-358-8046
63954	Katharine Rice	650-577-7829
67296	Michael Smith	530-624-5906
67405	Tara Stuart	678-490-6776
69481	Lucia Muntean	650-522-5813
69729	Patricia Rose	650-439-7525
69996	Reena Bajpai	650-849-3049
71507	Miguel Lopez	310-229-9904
72362	Jiangqiong Liu	650-574-3000
73686	Dana Broughton-Johnson	843-209-2885
73733	Lydia Choi	650-653-9461
75110	Russell Romeo	650-235-2431
76571	Shelley Lai	650-372-7600
76828	Eric Lee	650-425-2744
76948	Wei Chi Chou	213-716-5063
77602	Paola Dozzo	415-713-8805
77620	Wenlan Chen	614-266-3458
78832	Ryann Muir	650-524-3920
79719	Darrin Flanigan	650-528-0835
80191	Joshua Seitz	650-522-2437

Proceeding Documents

133

Notice: refund approved NOTICE

2025-07-01 FILING PARTY: BOARD

Download

Refund Request OTHER

2025-06-25 FILING PARTY: PETITIONER

Download

Institution Decision: Deny DECISION

2025-05-15 FILING PARTY: BOARD

Download

Patent Owner's Preliminary Sur-Reply OTHER

2025-04-09 FILING PARTY: PATENT OWNER

Download

2024

Ex. 2024 - Johns (2013) HIV Integrase Inhibitors Exhibit

2025-04-09 FILING PARTY: PATENT OWNER

Download

Cipla Limited vs. Gilead Sciences, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Cipla Limited

Represented By

Patent Owner / Respondent

Gilead Sciences, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund approved NOTICE

Refund Request OTHER

Institution Decision: Deny DECISION

Patent Owner's Preliminary Sur-Reply OTHER

Ex. 2024 - Johns (2013) HIV Integrase Inhibitors Exhibit

Ex. 2025 - Spreen (2013) Pharmacokinetics, Safety, and Monotherapy Antiviral Activity Exhibit

Ex. 1072 - Joint Submission in Response to January 3, 2022 Oral Order, DI 180 in Case No. 20-cv-00431-MN, dated January 6, 2022 Exhibit

Patent Owner's Updated Power of Attorney NOTICE

Ex. 1066 - Defendant Cipla Limited's Notice of Sotera Stipulation, DI 286 of Case No. 22-cv-00615-MN, dated March 27, 2025 Exhibit

Ex. 1068 - Email regarding Narrowing and Extension of Deadlines, dated February 20, 2025 Exhibit

Ex. 1067 - Email regarding proposal of stay for Case No. 22-cv-00615 from Defendants to Plaintiffs, dated November 14, 2024 Exhibit

Reply to Patent Owner's Preliminary Response OTHER

Ex. 1069 - Cover Page and Table of Contents for Defendants' Amended Invalidity Contentions regarding U.S. Patent Nos. 10,548,846, 10,385,067, 9,708,342, and 11,744,802 Exhibit

Ex. 1071 -Joint Claim Construction Brief, DI 263 of Case No. 22-cv-00615-MN, dated November 22, 2024 Exhibit

Ex. 1070 - Orange Book Patent and Exclusivity list for Bictegravir Sodium, Emtricitabine, Tenofovir Alafenamide Fumarate (BIKTARVY) Tablet EQ 50 mg base, 200 mg, EQ 25 mg base, retrieved on March 31, 2025 Exhibit

Updated Exhibit List NOTICE

Ex. 1065 - Memorandum Order, DI 280 of Case No. 22-cv-00615-MN, dated February 21, 2025 Exhibit

Patent Owner's Updated Mandatory Notices NOTICE

Ex. 1064 - Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA), DI 003 of Case No. 22-cv-00615-MN, dated May 9, 2022 Exhibit

Ex. 3001 Attorney Correspondence Exhibit

Order: Conduct of Proceeding ORDER

Ex. 2019 - Annotated Excerpt of Declaration of Prassana Jagannathan, M.D., Oct. 23, 2024 Exhibit

Ex. 2021 - Excerpt of Hal Martin Deposition Transcript, May 2, 2024 [Redacted] Exhibit

Patent Owner's Unopposed Combined Motion to Seal and Motion for Protective Order MOTION

Ex. 2022 - Gilead GS-9883 STR Development PDCS Group Meeting presentation, Aug. 12, 2015 [Redacted] Exhibit

Ex. 2012 - Excerpt of Defendants Laurus Labs Limited, Cipla Limited, and Lupin Limited’s Amended Initial Invalidity Contentions, Dec. 20, 2023 Exhibit

Ex. 2015 - Excerpt of Plaintiff Gilead Sciences, Inc’s Final Validity Contentions, Aug. 2, 2024 Exhibit

Ex. 2013 - Excerpt of Defendants Laurus Labs Limited, Cipla Limited, and Lupin Limited’s Final Invalidity Contentions, July 2, 2024 Exhibit

Ex. 2020 - Excerpt of Rebuttal Expert Report of David W.C. MacMillan, Ph.D. in ViiV Healthcare Co. v. Gilead Sciences, Inc., l:18-cv-00224-CFCCJB, Jan. 10, 2020 Exhibit

Ex. 2017 - Excerpt of Opening Expert Report of Prassana Jagannathan, M.D., Jan. 31, 2025 Exhibit

Ex. 2007 - U.S. Patent No. 10,548,846 Exhibit

Ex. 2011 - Excerpt of Federal Court Management Statistics, Sep. 30, 2024 Exhibit

Ex. 2008 - Stipulation and [Proposed] Order To Amend Scheduling Order, D.I. 159 Exhibit

Ex. 2010 - Stipulation and Order To Amend Scheduling Order, D.I. 160 Exhibit

Ex. 2016 - Stipulation and Order To Amend Scheduling Order, D.I. 200 Exhibit

Ex. 2014 - Defendants’ ’802 Patent Claim Chart, July 11, 2024 Exhibit

Patent Owner's Preliminary Response POPR

Ex. 2023 - Annotated U.S. Patent No. 11,744,802 Exhibit

Ex. 2009 - PACER Docket Report, Gilead Sciences, Inc. v. Lupin Ltd. et al., No. 1:22-cv-00615-MN (D. Del.) Exhibit

Ex. 2018 - Excerpt of Opening Expert Report of Jeffrey Winkler, Ph.D., Jan. 29, 2025 Exhibit

Ex. 2001 - Patent Owner Motion for Horwitz PHV Admission Ex. A - Horwitz Bio Exhibit

Patent Owner's Motion for Pro Hac Vice Admission of Rebecca T. Horwitz Under 37 C.F.R. § 42.10(c) OTHER

Ex. 2003 - Patent Owner Motion for Kelson PHV Admission Ex. A - Kelson Bio Exhibit

Ex. 2004 - Declaration of Taylor Kelson in Support of Patent Owner's Motion for Pro Hac Vice Admission of Taylor Kelson Under 37 C.F.R. § 42.10(c) Exhibit

Ex. 2005 - Patent Owner Motion for McBride PHV Admission Ex. A - McBride Bio Exhibit

Ex. 2006 - Declaration of J. Scott McBride in Support of Patent Owner's Motion for Pro Hac Vice Admission of J. Scott McBride Under 37 C.F.R. § 42.10(c) Exhibit

Patent Owner's Motion for Pro Hac Vice Admission of J. Scott McBride Under 37 C.F.R. § 42.10(c) OTHER

Ex. 2002 - Declaration of Rebecca T. Horwitz in Support of Patent Owner's Motion for Pro Hac Vice Admission of Rebecca T. Horwitz Under 37 C.F.R. § 42.10(c) Exhibit

Patent Owner's Motion for Pro Hac Vice Admission of Taylor Kelson Under 37 C.F.R. § 42.10(c) OTHER

Declaration of Christopher J. Sorenson in Support of Petitioner's Motion for Admission Pro Hac Vice Exhibit

Updated Exhibit List NOTICE

Petitioner's Motion for Admission Pro Hac Vice of Christopher J. Sorenson OTHER

Notice: Notice filing date accorded to petition NOTICE

Notice : Mandatory Notice NOTICE

Notice : Power of Attorney NOTICE

1008-Bowker 2002 Exhibit

1047A-Blass Chapter 1 2015 Exhibit

1027-Llibre 2012 Exhibit

1040-U.S. Patent 10,548,846 File History (Part 3 of 4) Exhibit

1044-BusinessWire Gilead Press Release Nov 5 2015 Exhibit

1055F-Remington Chapter 38 Exhibit

1055C-Remington Chapter 58 Exhibit

1043-Sabin Lancet 2008 Exhibit

Declaration of Christopher J. Sorenson in Support of Motion for Pro Hac Vice Admission Exhibit

1011-U.S. Patent No. 10,58,846 Exhibit